предыдущий|следующий

In vitro studies of the anti-inflammatory activity of micheliolide on myeloproliferative neoplasm cell lines

  • role： First author第一作者
  • Affiliation：

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China

    National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China

  • Introduction：陈猛，女，博士，主治医师
CHEN Meng12,  
  • Affiliation：

    Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medicial Sciences & Peking Union Medicial College, Tianjin 300020, China

LIU Jinqin3,  
  • Affiliation：

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China

    National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China

ZHANG Ying12,  
  • role： Corresponding author通信作者
  • Affiliation：

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China

    National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China

  • Email：shzhx0604@163.com
  • Introduction：Prof. SHI Zhexin, Ph.D., Chief Physician, Doctoral Supervisor. First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No.88, Changling Road, Xiqing District, Tianjin 300381. E-mail: shzhx0604@163.com
SHI Zhexin12*,  
  • Affiliation：

    Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medicial Sciences & Peking Union Medicial College, Tianjin 300020, China

XIAO Zhijian3

реферат

Целью настоящего исследования было изучение воздействия микелиолида на экспрессию факторов клетки происхождения опухоли костного мозга серии UKE-1 и клеток острого мегакариоцитарного лейкоза SET-2 через путь сигнала и активации транскрипции 3 (СTAT3) и ядерного транскрипционного фактора-κВ (NF-κB) и механизм влияния.

ключеви́че слова́

含笑内酯;骨髓增殖性肿瘤;cytokine;信号传导和转录激活因子3;核转录因子－κB

References

  1. [1].
    ARBER DA, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J]. Blood，2016，128(3)：462－463.
  2. [2].
    LUQUE PAZ D, KRALOVICS R, SKODA RC. Genetic basis and molecular profiling in myeloproliferative neoplasms [J]. Blood，2023，141(16)：1909－1921.
  3. [3].
    FISHER DAC, MALKOVA O, ENGLE EK, et al. Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia [J]. Leukemia, 2017, 31(9): 1962－1974.
  4. [4].
    LUSSANA F, RAMBALDI A. Inflammation and myeloproliferative neoplasms [J]. J Autoimmun，2017，85：58－63.
  5. [5].
    KOSCHMIEDER S, MUGHAL TI, HASSELBALCH HC, et al. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both [J]. Leukemia，2016，30(5)：1018－1024.
  6. [6].
    丁林芬，郭亚东，潘争红，等. 荷花玉兰叶中2个新的倍半萜 [J]. 中草药，2017，48(17)：3463－3468.
  7. [7].
    DING LF, SU J, PAN ZH, et al. Cytotoxic sesquiterpenoids from the leaves of Magnolia grandiflora[J]. Phytochemistry, 2018, 155: 182－190.
  8. [8].
    GACH K, JANECKA A. α-Methylene-γ-lactones as a novel class of anti-leukemic agents [J]. Anticancer Agents Med Chem, 2014, 14(5): 688－694.
  9. [9].
    丁林芬，程彬，晏通，等. 云南含笑果实中倍半萜类化学成分研究 [J]. 中草药，2017，48(13)：2608－2613.
  10. [10].
    马维维. 抗肿瘤干细胞脱半萜内酯类化合物的结构修饰 [D]. 天津：南开大学，2012.
  11. [11].
    盛磊，周杰诗，韩旭，等. ACT001通过STAT1/CIITA/MHC－Ⅱ通路发挥抗炎抗氧化活性治疗脓毒症引起的急性肺损伤 [J]. 中国药理学通报，2023，39(12)：2231－2239.
  12. [12].
    李咪咪，汉京霞，孙涛，等. 含笑内酯衍生物ACT001对肺纤维化的治疗作用研究 [J]. 中国药理学通报，2020，36(12)：1665－1673.
  13. [13].
    VIENNOIS E, XIAO B, AYYADURAI S, et al. Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer [J]. Lab Invest，2014, 94(9)：950－965.
  14. [14].
    FIEDLER W, HENKE RP, ERGÜN S, et al. Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome: a case report[J]. Cancer, 2000, 88(2): 344－351.
  15. [15].
    UOZUMI K, OTSUKA M, OHNO N, et al. Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles[J]. Leukemia, 2000, 14(1): 142－152.
  16. [16].
    VERSTOVSEK S, MESA RA, GOTLIB J, et al. Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial [J]. J Hematol Oncol，2017，10(1)：55.
  17. [17].
    ZHANG Q, LU Y, DING Y, et al. Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells [J]. J Med Chem，2012，55(20)：8757－8769.
  18. [18].
    QIN XY, JIANG XR, JIANG X, et al. Micheliolide inhibits LPS-induced inflammatory response and protects mice from LPS challenge [J]. Sci Rep，2016，17(6)：23240.
  19. [19].
    JI Q, DING YH, SUN Y, et al. Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells [J]. Oncotarget, 2016，7(40)：65012－65023.
  20. [20].
    张华宇，曹佳璐，郑冰元，等. 人参－玉竹药对抑制炎性小体NLRP1、NLRC4、AIM2活化及调控炎症因子表达的抗抑郁作用机制研究[J]. 北京中医药大学学报，2024, 47(7): 939－947.
  21. [21].
    任越，姚美村，霍晓乾，等．抗新型冠状病毒方剂基于花生四烯酸代谢通路防治“细胞因子风暴”的研究[J].中国中医杂志，2020，45(6)：1225－1231.
  22. [22].
    LIU XC, WANG XB. Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents [J]. Chin J Nat Med, 2022，20(11)：814－829.
  23. [23].
    蔡群兴. 菊花中小白菊内酯的超声提取及检测方法的研究 [D]. 合肥：安徽大学，2014.
  24. [24].
    徐静，高玲，谢永慧，等．倍半萜内酯化合物药理作用 [J]. 中国热带医学，2007，7(4)：623－624.
  25. [25].
    覃江江. 四种旋覆花属药用植物中新型倍半萜的发现及生物活性研究 [D]. 上海：上海交通大学，2011.
  26. [26].
    王世盛，张金梅，郭修晗，等. 温郁金中的新桉叶烷型倍半萜内酯 [J]. 药学学报，2007，42(10)：1062－1065.
  27. [27].
    李勇，丛斌，董玫，等. 土木香中倍半萜内酯抗肿瘤活性及构效关系研究 [J]. 中草药，2010，41(8): 1336－1338.
  28. [28].
    SAADANE A, MASTERS S, DIDONATO J, et al. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice [J]. Am J Respir Cell Mol Biol, 2007, 36(6): 728－736.

Читать полностью

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website